Medicine
Podofilox 5 mg/mL topical solution
Podofilox 5 mg/mL topical solution is a generic prescription medicine for topical use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store at 20° and 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Podofilox
- Brand
- Sold under the generic name
- Strength
- 5 mg/mL
- Dosage form
- Topical solution
- Route
- Topical
- Packs
- 1 bottle
- Manufacturer
- Padagis
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store at 20° and 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D06BB04 Podofilox
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 January 2002
- Identifiers
- RxCUI 582926DailyMed set ID 6af07697-5203-43e0-ba35-83683af851c3NDC 0574-0611Application ANDA075600
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, glass in 1 carton / 3.5 mL in 1 bottle, glass | 0574-0611-05 | Padagis | 29 January 2002 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 13 December 1990 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Podofilox
Clinical summary
Podofilox is a prescription medicine indicated for the topical treatment of anogenital warts (external genital warts and perianal warts). It is available as gel and topical solution. MedsAcross supplies Podofilox for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PodofiloxFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Podofilox prescribing information (Padagis) · U.S. National Library of Medicine, DailyMed
Need Podofilox 5 mg/mL topical solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.